Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G Stake Amended Statement of Ownership
  14. 8-K Event Material agreement · Other events
  15. 424B5 Offering Prospectus
  16. 8-K Event Results of operations · Other events
  17. 424B5 Offering Prospectus
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 8-K Event Other events
  20. 4 Open-market sale Chief Medical Officer sold 6,890 shares at an average $20.01 ($137,835)

Page 30 of 40 · 789 filings